FDA approves Flonase allergy relief for sale over-the-counter in the United States

Abstract:

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Flonase® Allergy Relief (fluticasone propionate 50 mcg spray), containing the No. 1 prescribed allergy treatment ingbkp_redient1, as an over-the-counter (OTC) treatment for temporary relief of the symptoms of hay fever or upper respiratory allergies. 2 Flonase® Allergy Relief is the first and only over-the-counter nasal spray indicated for relief of all nasal and eye-related allergy symptoms3, 4 including runny nose, sneezing, itchy nose5-7, nasal congestion8-11 and itchy and watery eyes. 12-15 Flonase® Allergy Relief will be available at full prescription strength and to provide 24-hour non-drowsy allergy relief.

Año de publicación:

Keywords:

Fuente:

google